Poor sales confirms nothing. Doctors are not scripting the drug plain and simple. They are stuck on Fen Phen and other weight loss drugs that hurt patients in the end. They are scared and uneducated, I have talked to a few and they were clueless about the drug.
Real world results of this drug is it is changing lives and helping people to lose a lot of weight in a healthy way. Helping them change their cravings and lifestyle slowing over a 9 to 12 month time period.
Only drug on the market right now is Belviq and Eisai is in total control of that drug. So a take out is difficult if you can't get Eisai to sign off. While the pipeline is filled with potential it is immature right now. Not enough data, which is why we are doing the Phase 2 proof of concept.. Once we have the data from both drugs completing the Phase 2 we will have something that will attract a buyer if the drugs are in fact as good as Jack has stated.
study? I understand that a Phase 2b can be counted as one of the Phase 3 studies needed to be done before they can file and NDA. The big question is will they survive to actually file a NDA
You really think we are going that low? We were not that low when we were still developing a drug and did not have the pipeline we have today.
Ha ha, I don't pump and I have not dumped, HENCE the frustration.
You can't point to a single pump in 3 years. And the fact that I see problems with management decisions or their faults and mistakes does not make me a pump and dumper.
I am sure longs would love me to just talk about how wonderful things are but looking at your investments through rosy glasses is a dangerous thing. Hence I am still holding and have now gone into the red by probably more then your entire net worth.
Still long because I believe in Belviq. I have watched it first hand help people who have not been able to lose weight for 10, 15 and 20 years get skinny and healthy. I just don't understand how a drug that helps people change their lives can be totally ignored and taken out behind the barn and shot. Even with bad decisions and mis steps the drug works so well "in the real world" the sales should be taking on a life of their own.
Not if we don't get any buyers... It takes buyers to move a stock price up and the large buying volume is non existent at this point.
These idiots have been looking at the market and analyzing the market for 9 months since the Phase 2 data was released and over a year and a half while they were doing the Phase 2 study...
They are complete morons.
Oh and stop allowing people to step in the middle of the trade when the rest of the market has to trade in whole cents. It allows insiders to buy and sell in front of someone else that has been time stamped and had their order in front of them. Whole penny trading would also help to curb stuff because the big boys would have to get in line and would face not getting filled as well.
The following would also help curb the games.
Real time totals of FTD, penalties and possible censure for those the violate the rules
Real time short interest, reporting the firms that are holding the short positions. Force them to report all short sales including prime relationships and internal shorts. It is not proprietary or top secret to know that Goldman Sacks has 20 million short shares on their books. You don't know who those shares are for...
Eliminate the Reg SHO loopholes that allow naked shorting to still exist.
Take away Dark Pools and Hedge Funds direct access to the markets. Compliance is not getting done in real time and after the fact does not help for market manipulation done minute by minute.
If it turns out that APD 334 is in fact as good as they studies showed we may have a drug that is equal to or better then Receptos and APD 334 is not that far behind. So a buyout of 7.3 Billion shows that the drug has value, tremendous value. We won't get an idea of how effective it is until the 12 week study has been completed and the results are released.
06:51:20 2.685 155,000 shares
06:51:07 2.70 48,480
Beats the heck out of 100, 200 and 300 lots
Yup Ispot recorded it
Recently Aired Tue, Aug 25, 2015 11:25 AM PT (30m ago)
Recently Aired On Fox News View All
Recently Aired During
The Real Story With Gretchen Carlson View All
National + Spot
Number of Versions
14,797 View All
Spot Spend Rank
Giving hedge funds and dark pools direct access to the markets and allowing them to use Market Maker loop holes for price discovery has warped the supply and demand model of the markets.
Things to correct it would be.
No naked short selling that includes the Reg SHO games.
Short interest reported in real time.
Disclose which firms are short, fair and transparent markets.
Penalties including losing your licenses for breaking the rules and heavy fines, set standard minimums so they do not have to be settled in court.
All FTD's are reported in real time and have to be corrected. If to many and from the same firm then penalties including censure are an option.
Take away direct access to computer Algos, force them to go through compliance desks. It will slow down the markets a little but that is fine...
Just some thoughts.